Summary
Original, respected and reliable market reports that provide critical business insights to the prospects for, and risks in, leading pharmaceutical markets.
Espicom's Pharmaceutical Market Outlook reports have been used by senior management in commerce and industry for 30 years. Why? Because our experienced team of researchers and analysts combine economic, scientific, demographic and language skills to produce an unmatched and critical evaluation of the operating environment for pharmaceutical companies.
Description
Original, respected and reliable market reports that provide critical business insights to the prospects for, and risks in, leading pharmaceutical markets.
Espicom's Pharmaceutical Market Outlook reports have been used by senior management in commerce and industry for 30 years. Why? Because our experienced team of researchers and analysts combine economic, scientific, demographic and language skills to produce an unmatched and critical evaluation of the operating environment for pharmaceutical companies.
An unmatched level of intelligence sourcing
Our full time team of experts regularly access over 1,200 primary source information points in regulatory authorities, health organisations, statistics offices and industry. Much of the information in the Pharmaceutical Market Outlook reports is not readily available in English elsewhere. Espicom partners with the widely regarded Economist Intelligence Unit (EIU) to provide up-to-date economic data - a constant requirement in these rapidly changing times.
Detailed analysis & novel forecasts
Assembling comprehensive data is one thing, but our strength lies in its interpretation. What does it mean and what are the implications for operations and business development? Our analysis is second to none and the economic and market forecasts are built on solid research principles and continually assessed to reflect current and anticipated market conditions.
Global Industry...
By 2016, the global pharmaceutical market, including pharmacy and hospital sales, is forecast to be worth around US$1.6 trillion at retail prices. High growth in emerging markets will leverage slow growth in developed markets. Cost-containment policies will be offset against market demands for more effective products. Health access will expand, due to increasing generic penetration.
Localisation
The local market is the operating environment in which companies have to work. Domestic priorities set the agenda that affects a company's operations, therefore the prevailing macroenvironment needs to be both understood and planned for. In this way, pharmaceutical companies have strengthened their capabilities to increase sales in local and international markets.
Beyond BRIC markets
The USA will continue to be the first worldwide economy, but other emerging markets will perform well, led by China, India, Russia and Brazil. However, a second wave of emerging markets will arise, namely South Korea, Mexico, Turkey, Indonesia and Poland. In an environment which is becoming more regulated, pharmaceutical producers are re-aligning their global strategies.
Quality information = business confidence
Any investment in market information must make a real return in terms of market knowledge and business efficiency. That demands the data is of the highest quality, thoroughly researched with primary sources and with insightful analysis and forecasts. Our team of analysts - with science, language and analysis skills - work full time to produce pharmaceutical market information that is second to none. With Pharmaceutical Market Outlook you get comprehensive market evaluation on which you can rely.
Guaranteed.
About Pharmaceutical Market Outlook
Pharmaceutical Market Outlook is a pharmaceutical market evaluation service published by Espicom Business Intelligence.It covers 63 key pharmaceutical markets worldwide. A
comprehensive report for each market is produced every three months. In addition comprehensive healthcare statistical intelligence is published annually.
You can buy individual market reports, or there is a series of regional collections that can be purchased at considerable discount. Please click on any country in the tables below to be taken to their individual page, or click The Outlook for Pharmaceuticals title to be taken to the collection page.
The Outlook for Pharmaceuticals in Central and Eastern Europe
Bulgaria
Croatia
Czech Republic
Hungary
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Ukraine
The Outlook for Pharmaceuticals in Northern Europe
Denmark
Estonia
Finland
Latvia
Lithuania
Norway
Sweden
The Outlook for Pharmaceuticals in Western Europe
Austria
Belgium
France
Germany
Ireland
Italy
The Netherlands
Portugal
Spain
Switzerland
UK
The Outlook for Pharmaceuticals in Central Asia
Bangladesh
China
India
Pakistan
The Outlook for Pharmaceuticals in South East Asia
Indonesia
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
The Outlook for Pharmaceuticals in North East Asia
China
Japan
South Korea
Taiwan
The Outlook for Pharmaceuticals in Latin America
Argentina
Brazil
Chile
Colombia
Cuba
Mexico
Peru
Venezuela
E7: The Outlook for Pharmaceuticals
Brazil
China
India
Indonesia
Mexico
Russia
Turkey
The Market for Pharmaceuticals in Brazil, Russia, India & China
Brazil
Russia
India
China
Mix and Match: If you have a specific need then you can build a custom set of market reports. Any number of markets can be included and a discount scheme means they are cost effective as well. For details please contact either the UK or US office. Full contact details are provided on our contact us page.
"We can get all this information off the Internet"
Very unlikely. Much of the analysis and forecasts in Pharmaceutical Market Outlook reports are unique - not to be found elsewhere. Furthermore, much of that information is not readily available in the public domain and some of it not available in English. While some sources of information on the Internet are trustworthy, others are not. Data is not always updated, and one must be ever cautious. Pharmaceutical Market Outlook analysts are in regular and routine contact with over 1200 key information sources in commerce and government including health ministries, companies, trade associations and statistics offices.
